Exelixis
EXEL
#1660
Rank
NZ$17.33 B
Marketcap
$60.70
Share price
1.26%
Change (1 day)
73.03%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $82.47 NZD on 2000-07-26

Lowest end of day price: $2.16 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$60.77-1.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
$85.94-0.79%๐Ÿ‡ซ๐Ÿ‡ท France
$172.34 1.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$90.66-1.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$544.68 1.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$260.33-0.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$44.74-1.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.40 1.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.12 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA